Prenatal care and systemic arterial hypertension previa in women with pre-eclampsia
DOI:
https://doi.org/10.21527/2176-7114.2025.50.14921Keywords:
pre-eclampsia, prenatal assistance, pregnant women, hypertensionAbstract
Hypertensive syndrome in pregnancy has become a serious global health problem, resulting in high hospitalization rates. The objective was to characterize women with preeclampsia treated at a public maternity hospital. This was a retrospective cross-sectional study of pregnant women hospitalized in a public maternity hospital in Piauí between 2017 and 2021, using the International Classification of Diseases (ICD)-10 O14. The sample consisted of 186 medical records. Measures of central tendency, separatrices, simple and relative frequencies, and a chi-square test with p<0.05 were used. The measure of the effect of the independent variables on the outcomes was the Prevalence Ratio (PR), measured by Poisson regression. Clinical and obstetric characterization revealed that 70.6% were multigravidae, 37.5% were nulliparous, and 17.7% had already had some type of abortion. The majority of deliveries were cesarean sections (76.2%). A total of 85.7% of pregnant women received prenatal care and 38.4% had up to 6 prenatal appointments, with 31% of pregnant women having their first appointment in the third trimester of pregnancy. Regarding the association of clinical characteristics with previous Systemic Arterial Hypertension (SAH), compared to full-term, preterm gestational age increases the chances of previous SAH by 2.78 times Regarding clinical characteristics and postpartum complications, preterm births increase the prevalence of postpartum complications by 5.0 times compared to full-term births. The prevalence of previous systemic arterial hypertension was 20.6%. Regarding prenatal care, 85.7% reported having attended prenatal care, with 38.4% reporting up to six appointments. Furthermore, 31% reported late initiation of prenatal care.
References
1. Pereira GT, Santos AAP dos, Silva JM de O e, Nagliate P de C. Epidemiological profile of maternal mortality due to hypertension: situational analysis of a northeastern state between 2004 and 2013. Rev. Res. (Univ. Fed. Estado Rio J., Online) [Internet]. 2017 Jul 11 [cited 2024 Sep 04];9(3):653-8. Available at: https://seer.unirio.br/cuidadofundamental/article/view/5526
2. Vale É de L, Cunha de Menezes LC, Bezerra INM, Frutuoso ES, Silva Gama ZA da, Wanderley VB, et al. Improving the quality of care for gestational hypertension in intensive care. Avances in Nursing. 2020 [cited 2024 Sep 04];38(1):55–65. Available at: http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0121-45002020000100055&lng=en.
3. Oliveira AC, Machado BC, Oliveira CF, Schneider FCC de A, Caixeta FC, Martins GS, et al. Epidemiological profile of pregnant women with eclampsia admitted in Cuiabá hospitals from 2008 to 2017. J Health Sci [Internet]. 2019 [cited 2023 Jan 04];21(4):414–6. Available from: https://seer.pgsskroton.com/index.php/JHealthSci/article/view/6758 . DOI: https://doi.org/10.17921/2447-8938.2019v21n4p414-6
4. Albert Einstein Brazilian Israelite Charitable Society. Technical note for organizing the health care network with a focus on primary health care and specialized outpatient care: women's health during pregnancy, childbirth, and puerperium [Internet]. São Paulo: Ministry of Health;2019 [cited 05 Jan 2023]. 56 p. Available at: https://atencaobasica.saude.rs.gov.br/upload/arquivos/202001/03091259-nt-gestante-planificasus.pdf .
5. Barroso WKS, Rodrigues CIS, Bortolotto LA, Mota-Gomes MA, Brandão AA, Feitosa AD de M, et al. Brazilian Guidelines for Hypertension – 2020. Arq Bras Cardiol 2021 [cited 2024 Sep 04];116(3):516–658. Available from: https://doi.org/10.36660/abc.20201238
6. World Health Organization. World Hypertension Day 2022 [Internet]. Geneva: WHO; 2021 [cited 08 Jan 2023]. Available at: https://www.paho.org/pt/campanhas/dia-mundial-da-hipertensao-2022 .
7. Brazil. Ministry of Health. Secretariat of Primary Health Care. Department of Programmatic Actions. High-Risk Pregnancy Manual . Brasília: MS; 2022.
8. Brazilian Federation of Gynecology and Obstetrics Associations. Preeclampsia. FEBRASGO guidelines and recommendations series [Internet]. 2017 [cited 06 Jan 2023];8. Available at: c hrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://www.febrasgo.org.br/media/k2/attachments/12-PRE_ECLAyMPSIA.pdf.
9. Ferreira ETM, Moura NS,Gomes MLS,Silva EG,Guerreiro MGS,Oriá MOB. Maternal characteristics and risk factors for preeclampsia in pregnant women. Rev Rene [Internet].2019 [cited 2023 Jan 6];20. Available from: https://www.redalyc.org/journal/3240/324058874027/html/ . DOI: 10.15253/2175-6783.20192040327.
10. Arechvo A, Voicu D, Gil MM, Syngelaki A, Akolekar R, Nicolaides KH. Maternal race and pre-eclampsia: Cohort study and systematic review with meta-analysis. BJOG. 2022;129(12):2082–93.
11. Fasanya HO, Hsiao CJ, Armstrong-Sylvester KR, Beal SG. A critical review on the use of race in understanding racial disparities in preeclampsia. J Appl Lab Med 2021;6(1):247–56.
12. Jacob LM da S, Santos AP, Lopes MHB de M, Shimo AKK. Socioeconomic, demographic and obstetric profile of pregnant women with Hypertensive Syndrome in a public maternity hospital. Rev Gaucha Enferm [Internet]. 2020 [cited 03 Jan 2023];41:e20190180. Available at: https://www.scielo.br/j/rgenf/a/6v85SkvTQmmwngp9z6rwgqQ/?lang=en#. DOI: 10.1590/1983-1447.2020.20190180
13. Mattsson K, Juárez S, Malmqvist E. Influence of Socio-economic factors and region of birth on the risk of preeclampsia in Sweden. Int J Environ Res Public Health. 2022;19(7):4080.
14. Soomro S, Kumar R, Lakhan H, Shaukat F. Risk factors for pre-eclampsia and eclampsia disorders in tertiary care center in Sukkur, Pakistan. Cureus [Internet]. 2019 [cited 04 Jan 2023];11(11):e6115. Available at: https://www.cureus.com/articles/24452-risk-factors-for-pre-eclampsia-and-eclampsia-disorders-in-tertiary-care-center-in-sukkur-pakistan#!/metrics. DOI: 10.7759/cureus.6115
15. Lisonkova S, Bone JN, Muraca GM, Razaz N, Wang LQ, Sabr Y, et al. Incidence and risk factors for severe preeclampsia, hemolysis, elevated liver enzymes, and low platelet count syndrome, and eclampsia at preterm and term gestation: a population-based study. Am J Obstet Gynecol. 2021;225(5):538.e1-538.e19.
16. Zhang N, Tan J, Yang H, Khalil RA. Comparative risks and predictors of preeclamptic pregnancy in the Eastern, Western and developing world. Biochem Pharmacol [Internet]. 2020 [cited 05 Jan 2023];182(114247):114247. Available at: https://pubmed.ncbi.nlm.nih.gov/32986983/. DOI:10.1016/j.bcp.2020.114247
17. Poon LC, Shennan A, Hyett JA, Kapur A, Hadar E, Divakar H, et al. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention. Int J Gynaecol Obstet [Internet]. 2019 [cited 03 Jan 2023];145 Suppl 1(S1):1–33. Available at: https://pubmed.ncbi.nlm.nih.gov/31111484/ . DOI: 10.1002 / ijgo.12802
18. Corrigan L, O'Farrell A, Moran P, Daly D. Hypertension in pregnancy: Prevalence, risk factors and outcomes for women giving birth in Ireland. Pregnancy Hypertension. 2021; 24:1–6.
19. Greenberg VR, Silasi M, Lundsberg LS, Culhane JF, Reddy UM, Partridge C, et al. Perinatal outcomes in women with elevated blood pressure and stage 1 hypertension. Am J Obstet Gynecol [Internet]. 2021 [cited 04 Jan 2023];224(5):521.e1-521.e11. Available at: https://www.ajog.org/article/S0002-9378(20)31279-5/fulltext . DOI: 10.1016/j.ajog.2020.10.049
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Morgana Boaventura Cunha, Maurício Batista Paes Landim
This work is licensed under a Creative Commons Attribution 4.0 International License.
By publishing in Revista Contexto & Saúde, authors agree to the following terms:
The works are licensed under the Creative Commons Atribuição 4.0 Internacional (CC BY 4.0) license, which allows:
Share — to copy and redistribute the material in any medium or format;
Adapt — to remix, transform, and build upon the material for any purpose, including commercial.
These permissions are irrevocable, provided that the following terms are respected:
Attribution — authors must be properly credited, with a link to the license and indication of any changes made.
No additional restrictions — no legal or technological measures may be applied that restrict the use permitted by the license.
Notes:
The license does not apply to elements in the public domain or covered by legal exceptions.
The license does not grant all rights necessary for specific uses (e.g., image rights, privacy, or moral rights).
The journal is not responsible for opinions expressed in the articles, which are the sole responsibility of the authors. The Editor, with the support of the Editorial Board, reserves the right to suggest or request modifications when necessary.
Only original scientific articles presenting research results of interest that have not been published or simultaneously submitted to another journal with the same objective will be accepted.
Mentions of trademarks or specific products are intended solely for identification purposes, without any promotional association by the authors or the journal.
License Agreement (for articles published from September 2025): Authors retain copyright over their article and grant Revista Contexto & Saúde the right of first publication.
